WAKEFIELD, Mass.--(BUSINESS WIRE)--Feb. 28, 2006--Implant Sciences Corporation (AMEX: “IMX”, “IMX.WS”) a developer and manufacturer of products for national security, medicine and industry, today announced the delivery of its Dual Activity Software Module (“DASM”) prototype to Dr. Gordon Grado at his Southwest Oncology Centers office in Scottsdale, Arizona. Dr. Grado is the Principal Clinical Investigator of the DASM project and was instrumental in the design and development of the software.
